Institute of Medicine finds mitochondrial replacement therapy is ethical

In findings released February 3, an  Institute of Medicine panel has deemed mitochondrial transfer therapy ethical. This has important implications for the basic research of OHSU’s Shoukhrat Mitalipov and colleagues in the Center for Embryonic and Gene Therapy, though a Congressional ban on researching this therapy in humans remains in effect.

Update: The IOM panel’s report has garnered major media interest–for example, see more here, here, here, and here.